These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 21652733)
1. A sensitized RNA interference screen identifies a novel role for the PI3K p110γ isoform in medulloblastoma cell proliferation and chemoresistance. Guerreiro AS; Fattet S; Kulesza DW; Atamer A; Elsing AN; Shalaby T; Jackson SP; Schoenwaelder SM; Grotzer MA; Delattre O; Arcaro A Mol Cancer Res; 2011 Jul; 9(7):925-35. PubMed ID: 21652733 [TBL] [Abstract][Full Text] [Related]
2. Targeting the PI3K p110alpha isoform inhibits medulloblastoma proliferation, chemoresistance, and migration. Guerreiro AS; Fattet S; Fischer B; Shalaby T; Jackson SP; Schoenwaelder SM; Grotzer MA; Delattre O; Arcaro A Clin Cancer Res; 2008 Nov; 14(21):6761-9. PubMed ID: 18980969 [TBL] [Abstract][Full Text] [Related]
3. Personalizing the treatment of pediatric medulloblastoma: Polo-like kinase 1 as a molecular target in high-risk children. Triscott J; Lee C; Foster C; Manoranjan B; Pambid MR; Berns R; Fotovati A; Venugopal C; O'Halloran K; Narendran A; Hawkins C; Ramaswamy V; Bouffet E; Taylor MD; Singhal A; Hukin J; Rassekh R; Yip S; Northcott P; Singh SK; Dunham C; Dunn SE Cancer Res; 2013 Nov; 73(22):6734-44. PubMed ID: 24019381 [TBL] [Abstract][Full Text] [Related]
4. Efficient inhibition of human colorectal carcinoma growth by RNA interference targeting polo-like kinase 1 in vitro and in vivo. Xu WJ; Zhang S; Yang Y; Zhang N; Wang W; Liu SY; Tian HW; Dai L; Xie Q; Zhao X; Wei YQ; Deng HX Cancer Biother Radiopharm; 2011 Aug; 26(4):427-36. PubMed ID: 21797676 [TBL] [Abstract][Full Text] [Related]
5. Combined gene expression profiling and RNAi screening in clear cell renal cell carcinoma identify PLK1 and other therapeutic kinase targets. Ding Y; Huang D; Zhang Z; Smith J; Petillo D; Looyenga BD; Feenstra K; Mackeigan JP; Furge KA; Teh BT Cancer Res; 2011 Aug; 71(15):5225-34. PubMed ID: 21642374 [TBL] [Abstract][Full Text] [Related]
6. Expression of MAGE and GAGE genes in medulloblastoma and modulation of resistance to chemotherapy. Laboratory investigation. Kasuga C; Nakahara Y; Ueda S; Hawkins C; Taylor MD; Smith CA; Rutka JT J Neurosurg Pediatr; 2008 Apr; 1(4):305-13. PubMed ID: 18377306 [TBL] [Abstract][Full Text] [Related]
7. Lentiviral shRNA screen of human kinases identifies PLK1 as a potential therapeutic target for osteosarcoma. Duan Z; Ji D; Weinstein EJ; Liu X; Susa M; Choy E; Yang C; Mankin H; Hornicek FJ Cancer Lett; 2010 Jul; 293(2):220-9. PubMed ID: 20144850 [TBL] [Abstract][Full Text] [Related]
8. [Study of growth inhibition of gastric cancer cells by sRNA targeting polo like kinase 1 in vitro and vivo]. Lan B; Liu BY; Cheng XH; Qu Y; Zhang XQ; Cai Q; Dai QB; Zhu ZG Zhonghua Wai Ke Za Zhi; 2006 Jan; 44(1):40-4. PubMed ID: 16620646 [TBL] [Abstract][Full Text] [Related]
9. Reciprocal activation between PLK1 and Stat3 contributes to survival and proliferation of esophageal cancer cells. Zhang Y; Du XL; Wang CJ; Lin DC; Ruan X; Feng YB; Huo YQ; Peng H; Cui JL; Zhang TT; Wang YQ; Zhang H; Zhan QM; Wang MR Gastroenterology; 2012 Mar; 142(3):521-530.e3. PubMed ID: 22108192 [TBL] [Abstract][Full Text] [Related]
10. Polo-Like Kinase 1 Pharmacological Inhibition as Monotherapy or in Combination: Comparative Effects of Polo-Like Kinase 1 Inhibition in Medulloblastoma Cells. Pezuk JA; Brassesco MS; Ramos PMM; Scrideli CA; Tone LG Anticancer Agents Med Chem; 2017; 17(9):1278-1291. PubMed ID: 28270075 [TBL] [Abstract][Full Text] [Related]
11. Up-regulation of survivin in oral squamous cell carcinoma correlates with poor prognosis and chemoresistance. Su L; Wang Y; Xiao M; Lin Y; Yu L Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 Oct; 110(4):484-91. PubMed ID: 20868995 [TBL] [Abstract][Full Text] [Related]
13. Oncogenic effect of Polo-like kinase 1 expression in human gastric carcinomas. Jang YJ; Kim YS; Kim WH Int J Oncol; 2006 Sep; 29(3):589-94. PubMed ID: 16865274 [TBL] [Abstract][Full Text] [Related]
14. Small molecule kinase inhibitor screen identifies polo-like kinase 1 as a target for neuroblastoma tumor-initiating cells. Grinshtein N; Datti A; Fujitani M; Uehling D; Prakesch M; Isaac M; Irwin MS; Wrana JL; Al-Awar R; Kaplan DR Cancer Res; 2011 Feb; 71(4):1385-95. PubMed ID: 21303981 [TBL] [Abstract][Full Text] [Related]
15. Effect of polo-like kinase 1 gene silence on cell cycle and drug resistance in K562/A02 cell. Liu L; Zou P; Zhang M; Tian L; Liu F Chin Med J (Engl); 2006 Apr; 119(7):605-8. PubMed ID: 16620704 [No Abstract] [Full Text] [Related]
16. Silencing of polo-like kinase (Plk) 1 via siRNA causes induction of apoptosis and impairment of mitosis machinery in human prostate cancer cells: implications for the treatment of prostate cancer. Reagan-Shaw S; Ahmad N FASEB J; 2005 Apr; 19(6):611-3. PubMed ID: 15661849 [TBL] [Abstract][Full Text] [Related]
17. Inhibition of Aurora Kinase A enhances chemosensitivity of medulloblastoma cell lines. El-Sheikh A; Fan R; Birks D; Donson A; Foreman NK; Vibhakar R Pediatr Blood Cancer; 2010 Jul; 55(1):35-41. PubMed ID: 20232424 [TBL] [Abstract][Full Text] [Related]
18. Protein kinase G type Ialpha activity in human ovarian cancer cells significantly contributes to enhanced Src activation and DNA synthesis/cell proliferation. Leung EL; Wong JC; Johlfs MG; Tsang BK; Fiscus RR Mol Cancer Res; 2010 Apr; 8(4):578-91. PubMed ID: 20371672 [TBL] [Abstract][Full Text] [Related]
19. Overexpression of Aurora-A kinase promotes tumor cell proliferation and inhibits apoptosis in esophageal squamous cell carcinoma cell line. Wang XX; Liu R; Jin SQ; Fan FY; Zhan QM Cell Res; 2006 Apr; 16(4):356-66. PubMed ID: 16617331 [TBL] [Abstract][Full Text] [Related]
20. Rapid functional screening of effective siRNAs against Plk1 and its growth inhibitory effects in laryngeal carcinoma cells. Lan H; Zhu J; Ai Q; Yang Z; Ji Y; Hong S; Song F; Bu Y BMB Rep; 2010 Dec; 43(12):818-23. PubMed ID: 21189159 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]